Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS)

Cotton, S, Devereux, G, Abbas, H, Briggs, A H, Campbell, K, Chaudhuri, R, Choudhury, G, Dawson, D, De Soyza, A, Fielding, S, Gompertz, S, Haughney, J, Lang, C C, Lee, A, MacLennan, G, MacNee, W, McCormack, K, McMeekin, N, Mills, N L, Morice, A, Norrie, J, Petrie, L, Price, D, Short, P, Vestbo, J, Walker, P, Wedzicha, J A, Wilson, A & Lipworth, B J 2022, 'Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS)', Trials, vol. 23, no. 1, 307. https://doi.org/10.1186/s13063-022-06226-8